Story
CDP Equity Takes €1 Billion Stake in Angelini Pharma to Fund Catalyst Acquisition
CDP Equity has purchased a 23.5% stake in Italian drugmaker Angelini Pharma for approximately €1 billion ($1.1 billion), according to a statement released Thursday confirming the deal's completion. The transaction was executed through a capital increase and is intended to support Angelini Pharma's acquisition of the U.S.-listed company Catalyst.
Deal Structure and Financing
The investment from CDP Equity, an Italian state-backed investment firm, provides significant capital for Angelini Pharma's expansion. The funds are earmarked specifically for the acquisition of Catalyst, a strategic move for the Italian pharmaceutical company to grow its presence in the U.S. market.
In a parallel transaction, the deal will also see funds managed by Blackstone invest an additional €1 billion in Angelini Pharma through preferred shares. This part of the transaction is still pending standard regulatory approvals.
AdAdvisory Roles
A number of major financial institutions advised on the complex financing arrangement. BNP Paribas acted as the sole global coordinator and bookrunner for the debt financing portion of the deal.
Morgan Stanley & Co. International plc served as the sole financial advisor to Angelini Pharma for securing the participation of both CDP Equity and Blackstone as financial partners.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.